Results 141 to 150 of about 242,918 (218)

Immunomodulatory effect of stereotactic ablative radiotherapy in lung cancer [PDF]

Polish Archives of Internal Medicine, 2017
openaire   +2 more sources

Comparison of prognosis between patients undergoing surgical resection and stereotactic ablative radiotherapy for early-stage lung cancer. [PDF]

BMC Cancer
Erdizci P, Ersöz Köse E, Akyıl M, Atinkaya Baytemir C, Rzazade R, Baysungur SV.   +5 more
europepmc   +1 more source

Abscopal responses following stereotactic ablative radiotherapy during immune checkpoint inhibitor therapy in metastatic renal cell carcinoma: protocol for the prospective multicentre observational AURICRE study in Japan. [PDF]

BMJ Open
Chen Z, Onishi H, Mitsui T, Nakao A, Yokomichi H, Tsukahara M, Mochizuki S, Marino K, Komiyama T.   +8 more
europepmc   +1 more source

How to Safely Deliver Stereotactic Ablative Radiotherapy With High-Dose or Multi-agent Systemic Therapy. [PDF]

Cureus
Bernard ME.
europepmc   +1 more source

Stereotactic ablative radiotherapy-driven immunosuppression is associated with poorer progression-free survival in cancer patients. [PDF]

Cancer Immunol Immunother
Oliver J, Reed H, Capitani L, Poon-King A, Young A, Milutinovic S, Kuczynski M, Nicholas O, Rackley T, Pembroke C, Godkin A, Gallimore AM.   +11 more
europepmc   +1 more source

Pathologic Responses to Stereotactic Ablative Radiotherapy in Combination With Nivolumab for Early Stage NSCLC: A Phase 2 Study. [PDF]

JTO Clin Res Rep
Schvartsman G, Amirato YM, Monfardini F, Prado Dos Santos G, Gomes DBD, de O M Koch L, Bibas BJ, Gomes O, Campregher PV, Severino P, Marti LC, Paes VR, Leaden L, Chate RC, Ribas JM, Sousa VAR, Taranto P, Moura F, Terra RM, Pires de Rezende AC, Samano MN.   +20 more
europepmc   +1 more source

Changes in splenic volumes following stereotactic ablative radiotherapy (SABR) to adrenal tumors. [PDF]

Clin Transl Radiat Oncol
Giraud N, Palacios MA, van Sornsen de Koste JR, Marzo AM, van Rossum PSN, Schneiders FL, Senan S.   +6 more
europepmc   +1 more source

Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial. [PDF]

J Clin Oncol
Wang JH, Sherry AD, Bazyar S, Sutera P, Radwan N, Phillips RM, Deek MP, Lu J, Dipasquale S, Deville C, DeWeese TL, Song DY, Wang H, Hobbs RF, Malek R, Dudley SA, Greco SC, Antonarakis ES, Marshall CH, Denmeade S, Paller CJ, Carducci MA, Pienta KJ, Oz OK, Ramotar M, Leenstra JL, Park SS, Abramowitz MC, Desai N, Berlin A, Stish BJ, Tang C, Tran PT, Kiess AP.   +33 more
europepmc   +1 more source

Salvage Resection for Local Failure after Stereotactic Ablative Radiotherapy for Pulmonary Malignancies: A Retrospective, Single-Center Study. [PDF]

J Chest Surg
Kim EC, Park S, Hong EJ, Na KJ, Park IK, Kang CH, Kim YT, Kim HJ.   +7 more
europepmc   +1 more source

Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial. [PDF]

BMJ Open
Bedir A, Hassan L, Wittenberg I, Müller JA, Oesterling F, Walles T, Stang A, Vordermark D, Medenwald D.   +8 more
europepmc   +1 more source